Enhanced hypoglycemic activity following intratracheal administration of insulin microcrystal suspension with injection adjuvant

Bioscience, Biotechnology and Biochemistry

Volumn 70, Issue 4, 2006, Pages 1003-1005

  Lee, Hyun Kyung ^a   Kwon, Jai Hyun ^a   Park, Sang Ha ^a   Kim, Chan Wha ^a  

^a Korea University   (South Korea)

Author keywords

Adjuvant; Instillation; Insulin; Lung; Microcrystal

Indexed keywords

BIOMATERIALS; BLOOD; GLUCOSE; GLYCEROL; HORMONES; ZINC;

ADJUVANT; INSTILLATION; LUNGS; MICROCRYSTALS;

INSULIN;

ANTIDIABETIC AGENT; CHLORIDE; INSULIN; PHARMACEUTICAL VEHICLES AND ADDITIVES; ZINC CHLORIDE; ZINC DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; CRYSTALLIZATION; GLUCOSE BLOOD LEVEL; INJECTION; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; SUSPENSION; TRACHEA;

ADJUVANTS, PHARMACEUTIC; ANIMALS; BLOOD GLUCOSE; CHLORIDES; CRYSTALLIZATION; HYPOGLYCEMIC AGENTS; INJECTIONS; INSULIN; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUSPENSIONS; TRACHEA; ZINC COMPOUNDS;

EID: 33646138244     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70.1003     Document Type: Article

References (15)

1. Laube, B. L., Benedict, G. W., and Dobs, A. S., The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes. Chest, 114, 1734-1739 (1998).
2. Patton, J. S., Bukar, J., and Nagarajan, S., Inhaled insulin. Adv. Drug Deliv. Rev., 35, 235-247 (1999).
3. Pillai, O., and Panchagnula, R., Insulin therapies: past, present and future. Drug Discov. Today, 6, 1056-1061 (2001).
4. Liu, F. Y., Shao, Z., Kildsig, D. O., and Mitra, A. K., Pulmonary delivery of free and liposomal insulin. Pharm. Res., 10, 228-232 (1993).
5. Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., and Langer, R., Large porous particles for pulmonary drug delivery. Science, 276, 1868-1871 (1997).
6. Kwon, J. H., and Kim, C. W., Korea Patent 0327597 (Feb. 23, 2002).
7. Kwon, J. H., and Kim, C. W., A novel insulin microcrystal preparation using a seed zone method. J. Crystal Growth, 263, 536-543 (2004).
8. Kwon, J. H., Lee, B. H., Lee, J. J., and Kim, C. W., Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery. Eur. J. Pharm. Sci., 22, 107-116 (2004).
9. Choi, S. H., Kwon, J. H., and Kim, C. W., Microencapsulation of insulin microcrystals. Biosci. Biotechnol. Biochem., 68, 749-752 (2004).
10. Hirai, S., Yashiki, T., and Mima, H., Effect of surfactants on the nasal absorption of insulin in rats. Int. J. Pharm., 9, 165-172 (1981).
11. Felig, P., Landmark perspective: protamine insulin: Hagedorn's pioneering contribution to drug delivery in the management of diabetes. J. Am. Med. Assoc., 251, 393-396 (1984).
12. Ilouz, R., Kaidanovich, O., Gurwitz, D., and Eldar-Finkelman, H., Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem. Biophys. Res. Commun., 295, 102-106 (2002).
13. Kojima, Y., Yoshikawa, Y., Ueda, E., Ueda, R., Yamamoto, S., Kumekawa, K., Yanagihara, N., and Sakurai, H., Insulinomimetic zinc(II) complexes with natural production: in vitro evaluation and blood glucose lowering effect in KK-Ay mice with type 2 diabetes mellitus. Chem. Pharm. Bull., 51, 1006-1008 (2003).
14. Brange, J., Havelund, S., Hommel, E., Sorensen, E., and Kuhl, C., Neutral insulin solutions physically stabilized by addition of Zn2+. Diabet. Med., 3, 532-536 (1986).
15. Schlichtkrull, J., Insulin crystals: chemical and biological studies on insulin crystals and insulin zinc suspensions. Acta Chem. Scand., 10, 1459 (1961).